Target intelligence / Profile preview

Bacterial DNA synthesis enzymes (null)

Target
null
Molecular classification
Enzyme, DNA polymerase family (A, B, C types for prokaryotes), Helicase, Ligase, Topoisomerase, Primase
01

Overview

Bacterial DNA synthesis enzymes" collectively refer to proteins required for the replication, repair, and maintenance of bacterial DNA. The principal members include DNA polymerase III (the major replicative enzyme), DNA polymerase I (primarily required for repair and RNA primer removal), DNA polymerase II (mainly repair), DNA helicase (unwinds double-stranded DNA), DNA gyrase and topoisomerase IV (manage DNA supercoiling and segregation), RNA primase (synthesizes RNA primers needed for DNA polymerization), and DNA ligase (joins Okazaki fragments in lagging strand synthesis)[7][2][6][1][4]. These enzymes act in a coordinated fashion as part of the bacterial replisome[6]. Many antibiotics target these enzymes or their associated processes to inhibit bacterial proliferation, making them central therapeutic targets in infectious disease[7][6]. The term "Bacterial DNA synthesis enzymes" is not a specific molecular name but a class designation encompassing several essential and well-characterized bacterial enzymes.

Other names
DNA replication enzymesprokaryotic DNA polymerasesbacterial replisome components
02

Mechanism of action

Inhibition of DNA synthesis (polymerization blockade) Interference with DNA supercoiling and unwinding Disruption of primer formation Prevention of Okazaki fragment ligation Induction of DNA strand breaks

03

Biological functions

DNA synthesis (polymerization)DNA repairDNA unwindingRNA primer synthesisLigation of DNA fragmentsRelaxation and resolution of DNA supercoiling
04

Disease associations

InfectionAntibiotic resistanceOther (as targets of antibacterial therapy)
05

Safety considerations

Off-target effects on human homologous enzymes (topoisomerases, polymerases)Bacterial resistance by gene mutation or effluxPotential myelosuppression with some DNA synthesis inhibitorsRisk of DNA damage and mutagenesis
06

Interacting drugs

Quinolones and fluoroquinolones (target DNA gyrase/topoisomerase)

5 more in the full profile.

07

Biomarkers

Bacterial genetic markers for antibiotic resistance (e.g. mutations in gyrA and parC for fluoroquinolone resistance)Expression levels of repair enzymes as diagnostic markers

Beyond the preview

Go deeper on Bacterial DNA synthesis enzymes (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial DNA synthesis enzymes (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call